Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patents
Biotech
Appeals court reignites row over CRISPR discovery
Years after a body ruled in favor of teams behind Editas' IP, a court has found fault with the decision and sent the case back for reassessment.
Nick Paul Taylor
May 13, 2025 8:00am
Insulet buys Bigfoot’s automated insulin delivery patents
Feb 13, 2023 11:54am
CRISPR pioneers Doudna, Charpentier win Nobel Prize in chemistry
Oct 7, 2020 10:15am
Moderna patent case spurs concern for COVID-19 vaccine progress
Jul 24, 2020 8:50am
Alector, Prevail trade blows over founder's work
Aug 16, 2019 8:15am
Concert’s alopecia drug hits phase 2 endpoint with more data to come
Nov 12, 2018 10:37am